TIDMAMS

RNS Number : 1684V

Advanced Medical Solutions Grp PLC

31 October 2017

31 October 2017

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Total Voting Rights

In accordance with Disclosure and Transparency Rule 5.6.1, the issued share capital of Advanced Medical Solutions Group plc as at 31 October 2017 comprises 212,359,961 ordinary shares of 5p each with voting rights. There are no shares held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

   -     Ends -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                  Tel: +44 (0) 
  plc                                               1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications                Tel: +44 (0) 
                                                   20 3709 5700 
 Mary-Jane Elliott / Matthew Neal       AMS@consilium-comms.com 
  / Philippa Gardner / Rosie Phillips 
 
 Investec Bank PLC (NOMAD & Broker)                Tel: +44 (0) 
                                                   20 7597 5970 
 Daniel Adams / Gary Clarence 
  / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVREAXEFDFLXFFF

(END) Dow Jones Newswires

October 31, 2017 13:16 ET (17:16 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.